Intervention Review

HMG CoA reductase inhibitors (statins) for dialysis patients

  1. Sankar D Navaneethan1,*,
  2. Sagar U Nigwekar2,
  3. Vlado Perkovic3,
  4. David W Johnson4,
  5. Jonathan C Craig5,
  6. Giovanni FM Strippoli6

Editorial Group: Cochrane Renal Group

Published Online: 8 JUL 2009

Assessed as up-to-date: 20 JUL 2008

DOI: 10.1002/14651858.CD004289.pub4

Database Title

Additional Information

How to Cite

Navaneethan SD, Nigwekar SU, Perkovic V, Johnson DW, Craig JC, Strippoli GFM. HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database of Systematic Reviews 2009, Issue 3. Art. No.: CD004289. DOI: 10.1002/14651858.CD004289.pub4.

Author Information

  1. 1

    Glickman Urological and Kidney institute, Cleveland Clinic, Department of Nephrology and Hypertension, Cleveland, OH, USA

  2. 2

    University of Rochester School of Medicine and Dentistry, Rochester General Hospital, Rochester, NY, USA

  3. 3

    The George Institute for International Health, Renal Division, Camperdown, NSW, Australia

  4. 4

    Princess Alexandra Hospital, Department of Nephrology, Woolloongabba, QLD, Australia

  5. 5

    School of Public Health, The University of Sydney, Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, NSW, Australia

  6. 6

    The Children's Hospital at Westmead, Centre for Kidney Research, Westmead, NSW, Australia

*Sankar D Navaneethan, Department of Nephrology and Hypertension, Glickman Urological and Kidney institute, Cleveland Clinic, Cleveland, OH, 44195, USA. navanes@ccf.org. sankardass@hotmail.com.

Publication History

  1. Publication Status: Edited (conclusions changed)
  2. Published Online: 8 JUL 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (59K)Standard (410K)Full (560K)

  1. Current Version

    HMG CoA reductase inhibitors (statins) for dialysis patients

    Sankar D Navaneethan, Sagar U Nigwekar, Vlado Perkovic, David W Johnson, Jonathan C Craig and Giovanni FM Strippoli

    Article first published online: 8 JUL 2009 | DOI: 10.1002/14651858.CD004289.pub4

Previous versions of this article and their online publication dates

  1. Version 3

    HMG CoA reductase inhibitors (statins) for dialysis patients

    Sankar D Navaneethan, Sagar U Nigwekar, Vlado Perkovic, David W Johnson, Jonathan C Craig and Giovanni FM Strippoli

    Article first published online: 15 APR 2009 | DOI: 10.1002/14651858.CD004289.pub3

  2. Version 2

    HMG CoA reductase inhibitors (statins) for dialysis patients

    Sankar D Navaneethan and Rakesh Shrivastava

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD004289.pub2

  3. Version 1

    HGM CoA reductase inhibitors (statins) for lowering cholesterol in dialysis patients

    SD Navaneethan and R Shrivastava

    Article first published online: 19 JUL 2004 | DOI: 10.1002/14651858.CD004289

View Full Article (HTML) Summary (59K)Standard (410K)Full (560K)